EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Postintravitreal Dexamethasone Implant (OZURDEX®) – Induced Ocular Hypotony in Patients with Rheumatological Disease: A Rare Complication

Jayamadhury Gudimetla, R Madhukumar, Tata Monika, Kanchana Swathi Padma

Journal of Ophthalmology Clinics and Research · 2024

DOI: 10.4103/jocr.jocr_14_26 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Ophthalmology Clinics and Research, 2024. Verfasst von Jayamadhury Gudimetla und 3 weiteren Autor:innen. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dexamethasone intravitreal implant (OZURDEX ® ) is widely used in the management of inflammatory and edematous ocular conditions, including those associated with systemic rheumatological diseases. While generally considered safe, rare complications such as ocular hypotony have been reported, particularly in eyes with underlying structural and inflammatory vulnerability. We report two cases of young females with a history of rheumatological disease who developed hypotony after being treated with OZURDEX ® for recurrent macular edema. Both patients showed reduced intraocular pressure within 48 h postinjection without any structural complications or evidence of wound leak and recovered spontaneously without any active intervention. Patients with inflammatory or rheumatological conditions may have increased susceptibility to postinjection hypotony. These cases show the significance of cautious patient selection, preprocedural assessment, and close postinjection monitoring to reduce risk and assure positive outcomes.

Zitieren

APA

Gudimetla, J., Madhukumar, R., Monika, T., & Padma, K. S. (2024). Postintravitreal Dexamethasone Implant (OZURDEX®) – Induced Ocular Hypotony in Patients with Rheumatological Disease: A Rare Complication. Journal of Ophthalmology Clinics and Research. https://doi.org/10.4103/jocr.jocr_14_26

Vancouver

Gudimetla J, Madhukumar R, Monika T, Padma KS. Postintravitreal Dexamethasone Implant (OZURDEX®) – Induced Ocular Hypotony in Patients with Rheumatological Disease: A Rare Complication. Journal of Ophthalmology Clinics and Research. 2024. doi:10.4103/jocr.jocr_14_26

BibTeX
@article{Gudimetla2024,
  author = {Gudimetla, Jayamadhury and Madhukumar, R and Monika, Tata and Padma, Kanchana Swathi},
  title = {Postintravitreal Dexamethasone Implant (OZURDEX®) – Induced Ocular Hypotony in Patients with Rheumatological Disease: A Rare Complication},
  journal = {Journal of Ophthalmology Clinics and Research},
  year = {2024},
  doi = {10.4103/jocr.jocr_14_26}
}
Kostenlos starten →